Skip to main content
logo
Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
483.97
-3.03 (-0.62%)
At close: Feb 19, 2026

Revenue

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Roche Pharmaceuticals Revenue
44.79B43.30B
Roche Pharmaceuticals Revenue Growth
3.44%6.85%
Chugai Revenue
2.88B2.87B
Chugai Revenue Growth
0.28%-23.26%
Pharmaceuticals Revenue
47.67B46.17B
Pharmaceuticals Revenue Growth
3.24%4.31%
Diagnostics Revenue
13.85B14.32B
Diagnostics Revenue Growth
-3.33%-0.88%

Revenue by Geography

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Switzerland Revenue
819.00M747.00M
Switzerland Revenue Growth
9.64%10.02%
Germany Revenue
3.12B2.93B
Germany Revenue Growth
6.63%2.13%
Rest of Europe Revenue
10.86B10.29B
Rest of Europe Revenue Growth
5.53%6.06%
Europe Revenue
14.80B13.97B
Europe Revenue Growth
5.98%5.41%
United States Revenue
29.50B28.90B
United States Revenue Growth
2.08%6.32%
Rest of North America Revenue
972.00M889.00M
Rest of North America Revenue Growth
9.34%6.21%
North America Revenue
30.48B29.79B
North America Revenue Growth
2.30%6.32%
Latin America Revenue
3.25B3.25B
Latin America Revenue Growth
-0.12%9.36%
Japan Revenue
3.04B3.15B
Japan Revenue Growth
-3.77%-27.89%
Rest of Asia Revenue
8.60B9.09B
Rest of Asia Revenue Growth
-5.35%2.19%
Asia Revenue
11.63B12.24B
Asia Revenue Growth
-4.94%-7.73%
Africa, Australia and Oceania Revenue
1.36B1.25B
Africa, Australia and Oceania Revenue Growth
8.80%3.14%

EBIT

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Roche Pharmaceuticals Operating Profit
18.64B12.34B
Roche Pharmaceuticals Operating Profit Growth
51.12%-15.77%
Chugai Operating Profit
3.23B3.21B
Chugai Operating Profit Growth
0.40%10.19%
Pharmaceuticals Operating Profit
21.67B15.59B
Pharmaceuticals Operating Profit Growth
39.00%-12.97%
Diagnostics Operating Profit
1.07B1.95B
Diagnostics Operating Profit Growth
-45.02%39.80%
Corporate Operating Profit
-4.26B-4.12B

Capital Expenditures

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Roche Pharmaceuticals Capital Expenditures
6.68B6.00B
Roche Pharmaceuticals Capital Expenditures Growth
11.19%-30.87%
Chugai Capital Expenditures
595.00M350.00M
Chugai Capital Expenditures Growth
70.00%-28.57%
Pharmaceuticals Capital Expenditures
7.27B6.35B
Pharmaceuticals Capital Expenditures Growth
14.43%-30.75%
Diagnostics Capital Expenditures
2.20B2.44B
Diagnostics Capital Expenditures Growth
-9.81%-7.83%
Corporate Capital Expenditures
53.00M78.00M
Corporate Capital Expenditures Growth
-32.05%-11.36%
Updated Dec 31, 2025. Data Source: Fiscal.ai.